DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20151137

Clinical profile of the first 1000 fatalities for influenza A (H1N1) in Mexico

Germán Fajardo-Dolci, Rafael Gutiérrez-Vega, Luis Durán-Arenas, Luz del Carmen Hernández-Ramírez, Carlos Garrido-Solano, Jesús Franco-Marina, Juan García-Moreno, Alan Isaac Valderrama-Treviño, Eduardo E. Montalvo-Javé

Abstract


Background: Influenza is an acute respiratory disease responsible for several episodes of high mortality throughout human history. In 2009, Mexico experienced an atypical influenza outbreak caused by a mutant strain of the influenza A (H1N1) subtype, which generated significant mortality. The aim of this paper was to analyze the clinical and sociodemographic conditions of the first 1000 fatalities recorded during this outbreak.

Methods: We conducted a study based on an analysis of the clinical files of patients positive for influenza A (H1N1) using Real-Time-Polymerase Chain Reaction (RT-PCR) to conduct an analysis of deaths compared to deaths in the general population.  

Results: The majority of deaths occurred in patients aged 35-84 years (65.8%). Average time between symptom onset and death was 13.8 days, with an average of 7.8 days from time of hospitalization until death. Ca. 25% of deaths occurred in residents from Mexico City and from the nearby State of Mexico. In the majority of cases, we found that patients who died had a low educational and socioeconomic status along with co-morbidities such as metabolic syndrome and its individual components, as well as respiratory illnesses. In 80% of cases, patients received mechanical ventilation, and a similar percentage received antiviral therapy (oseltamivir, zanamivir).  

Conclusions: The primary-care level was not utilized by patients who died from influenza. The higher prevalence of chronic degenerative diseases among deaths compared with the general population indicates that these groups of patients should be considered and prioritized in the event of future outbreaks.

 


Keywords


Influenza A (H1N1), Clinical profile, Socioeconomic and educational status, Clinical features

Full Text:

PDF

References


Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, Finelli L, Shaw MW, Garten RJ, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605-15.

Abelin A, Colegate T, Gardner S, Hehme N, Palache A. Lessons from pandemic influenza A (H1N1): the research-based vaccine industry’s perspective. Vaccine. 2011;29:1135-8.

Kieny MP. WHO supports fair access to influenza A (H1N1) vaccine. Bull World Health Organ. 2009;87:653-4.

Krunic N, Merante F, Yaghoubian S, Himsworth D, Janeczko R. Advances in the diagnosis of respiratory tract infections: role of the Luminex xTAG respiratory viral panel. Ann N Y Acad Sci. 2011;1222:6-13.

Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Pérez L, de la Torre A, et al. Critically ill patients with 2009 influenza A (H1N1) in Mexico. N Engl J Med. 2009;361:680-9.

Pérez-Padilla R, de la Rosa-Zamboni D, Ponce de León S, Hernández M, Quiñones-Falconi F, Bautista E, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;360:2616-25.

Fajardo-Dolci G, Gutiérrez-Vega R, Arboleya-Casanova H, Villalobos A, Wilson KS, García SG, et al. Clinical characteristics of fatalities due to influenza A (H1N1) virus in Mexico. Thorax. 2010;65:505-9.

Domínguez A, Alonso J, Astray J, Baricot M, Cantón R, Castilla J, et al. Risk factors of influenza (H1N1) 2009 hospitalization and effectiveness of pharmaceutical and nonpharmaceutical interventions in its prevention: a case-control study. Rev Esp Salud Publica. 2011;85:3-15.

Santa-Olalla Peralta P, Cortes García M, Martínez Sánchez EV, Nogareda Moreno F, Limia Sánchez A, Pachón Del Amo I, et al. Enhanced surveillance of initial cases of pandemic influenza (H1N1) 2009 infection in Spain, April-June 2009. Rev Esp Salud Publica. 2010;84:529-46.

Baehr MF, Morín RG, Del Solar HJA, Olivi RH, Torres TJP. Clinical features of adults younger and older than 50 years hospitalized with influenza A H1N1 2009 in a private hospital in Santiago, Chile. Rev Chil Infect. 2010;27:139-43.

Santa-Olalla Peralta P, Cortes García M, Limia Sánchez A, Andrés Prado J, Pachón Del Amo I, Sierra Moros MJ, et al. Critically ill patients with 2009 pandemic influenza A (H1N1) infection in Spain: factors associated with death. Rev Esp Salud Publica. 2010;84:547-67.